AfricaHepC 2016 - International Conference on Hepatitis C AfricaHepC 2016

The WHO in 2014 estimated that 3% (about 170 million) of the world’s population were chronically infected with Hepatitis C. Hepatitis C is found worldwide. The most affected areas are Africa and Asia. IASTED’s International Conference on Hepatitis C (AfricaHepC 2016) will serve as an interdisciplinary forum for doctors, scientists, engineers, governments, organizations, and the general public to exchange information, review technologies, and research results with the aim of developing strategies to reduce and possibly eradicate this disease. Special attention to be given to countries in Africa.
Scope
The topics of interest to be covered by AfricaHepC 2016 include, but are not limited to:
Affordable testing and treatment
Barriers to effective care of patients
Case studies
Cost and access to therapy
Current treatment options
Education
Future treatment options
Government role
Interactions with other drugs
International cooperation
Management of disease in difficult to treat cases
Management requirements of various patient populations
Media role
Modelling and simulation
Molecular basis
Nongovernmental and associations role
Patient evaluation
Prevention and control
Public health issues
Research and development
Resistance to antiviral therapy
Screening and diagnostic tests
Side effects and effectiveness of therapies
Strategies for reduction and possibly eradication
Symptoms of HCV
The state of HCV in Africa
Treatment failures
Industry and private individuals role